About
With locations in Northbrook, Illinois, Chicago, and New Jersey, Marathon Pharmaceuticals focuses on developing treatment options for rare diseases. Marathon focuses on the creation of small-volume, hard-to-manufacture medications that are often overlooked by larger pharmaceutical companies – in addition to its offices, Marathon recently announced the opening of the Marathon Bioscience Center in Chicago, which focuses on the development of treatments for cancer, central nervous system diseases, movement disorders, gastrointestinal diseases, and endocrine deficiencies. Marathon’s goal is to get therapies into the hands of patients who need them the most, all while ensuring the quality of their products. The staff at the bioscience center is composed of clinical, research, and regulatory staff who work in tandem to produce next-generation treatments for rare diseases. Outside of prescription medications, Marathon is also constructing a pipeline of treatments for rare cancers and neurolo
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 34 investors are based in Northbrook, Illinois, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Northbrook, US
Contact Information
Find more investors like Marathon
Search Investors